Matches in Wikidata for { <http://www.wikidata.org/entity/Q60449339> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q60449339 description "artículu científicu espublizáu en setiembre de 2006" @default.
- Q60449339 description "im September 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q60449339 description "scientific article published on 01 September 2006" @default.
- Q60449339 description "wetenschappelijk artikel" @default.
- Q60449339 description "наукова стаття, опублікована у вересні 2006" @default.
- Q60449339 name "Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer" @default.
- Q60449339 name "Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer" @default.
- Q60449339 type Item @default.
- Q60449339 label "Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer" @default.
- Q60449339 label "Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer" @default.
- Q60449339 prefLabel "Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer" @default.
- Q60449339 prefLabel "Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer" @default.
- Q60449339 P1433 Q60449339-5A59D988-ABF6-4D1F-A620-D9B56779651E @default.
- Q60449339 P1476 Q60449339-5B2C5121-9823-4C12-9D40-44E16AE1B2ED @default.
- Q60449339 P2093 Q60449339-4A0316A2-4725-4877-A9D1-7C7C71B97681 @default.
- Q60449339 P2093 Q60449339-66AC1BF8-37AA-4D23-BD06-7C44CE21070F @default.
- Q60449339 P2093 Q60449339-7C6766E5-15EE-45E2-A12D-F449272A1338 @default.
- Q60449339 P2093 Q60449339-A06F4492-0234-443F-B81C-7C266D6DDC3B @default.
- Q60449339 P2093 Q60449339-B5520921-E1DD-4C95-BEB6-BD569F02DD0C @default.
- Q60449339 P2093 Q60449339-BBCAED43-53CB-4DDC-8DBA-53840C9321C4 @default.
- Q60449339 P2093 Q60449339-BC603BD8-926B-4024-AD84-A6E84902E267 @default.
- Q60449339 P2093 Q60449339-CF502FA9-3C88-4AED-83FB-33F73E893658 @default.
- Q60449339 P2093 Q60449339-D5CBB963-43FB-4D54-9D8F-45B98BA0B5B3 @default.
- Q60449339 P2093 Q60449339-E8969631-B03B-4860-B438-8F880B1E5890 @default.
- Q60449339 P304 Q60449339-C0DE5F73-4DA6-4168-A3B9-41F45204263D @default.
- Q60449339 P31 Q60449339-3B9F28A1-A8F5-442C-9DD8-F4D58D1DBA32 @default.
- Q60449339 P356 Q60449339-9CF87F6C-9276-476C-8B24-2B89073C288D @default.
- Q60449339 P407 Q60449339-D9CE12AA-480B-4FA1-BFED-0737C062DB3F @default.
- Q60449339 P433 Q60449339-2A689B8C-D26A-4B35-81FD-9A6E2BBD2DEA @default.
- Q60449339 P478 Q60449339-13331DF3-557D-47BB-A399-09E56D2EA9CC @default.
- Q60449339 P50 Q60449339-CDD787F5-78B0-4035-9028-085EFC62BC11 @default.
- Q60449339 P577 Q60449339-DA244C2A-187C-4BEF-913D-9125BCC0165A @default.
- Q60449339 P698 Q60449339-5051DE9D-6FBD-45AE-80B3-D4DA50583753 @default.
- Q60449339 P921 Q60449339-494ADFBB-7F32-4D8E-B21A-C4736C210671 @default.
- Q60449339 P921 Q60449339-4A56E008-5B3A-4C0C-B73D-EABEC8A0B9C0 @default.
- Q60449339 P921 Q60449339-ACAEF7F9-68B1-4AB1-AD35-DA8279ED778D @default.
- Q60449339 P921 Q60449339-C07634B2-4031-4717-8EF4-59A2D9477CE3 @default.
- Q60449339 P356 JCO.2006.06.7835 @default.
- Q60449339 P698 16983108 @default.
- Q60449339 P1433 Q400292 @default.
- Q60449339 P1476 "Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer" @default.
- Q60449339 P2093 "Binh Nguyen" @default.
- Q60449339 P2093 "Corey Langer" @default.
- Q60449339 P2093 "Frances Shepherd" @default.
- Q60449339 P2093 "Glen J Weiss" @default.
- Q60449339 P2093 "Lawrence H Einhorn" @default.
- Q60449339 P2093 "Nasser Hanna" @default.
- Q60449339 P2093 "Patrick McAndrews" @default.
- Q60449339 P2093 "Paul A Bunn" @default.
- Q60449339 P2093 "Rafael Rosell" @default.
- Q60449339 P2093 "Sofia Paul" @default.
- Q60449339 P304 "4405-4411" @default.
- Q60449339 P31 Q13442814 @default.
- Q60449339 P356 "10.1200/JCO.2006.06.7835" @default.
- Q60449339 P407 Q1860 @default.
- Q60449339 P433 "27" @default.
- Q60449339 P478 "24" @default.
- Q60449339 P50 Q46672616 @default.
- Q60449339 P577 "2006-09-01T00:00:00Z" @default.
- Q60449339 P698 "16983108" @default.
- Q60449339 P921 Q420436 @default.
- Q60449339 P921 Q42824827 @default.
- Q60449339 P921 Q47912 @default.
- Q60449339 P921 Q974135 @default.